- Zacks•last month
Bioanalytical recently introduced the 'Embrace Automation grant program' featuring 'BASi Culex NxT Automated Blood Sampling system and Raturn.'
- Business Wire•last month
Bioanalytical Systems, Inc. , a recognized global leader in the development of instrumentation for automated blood sampling in animal models, is proud to announce its launch of the Embrace Automation grant program featuring the BASi Culex NxT ™ Automated Blood Sampling system and Raturn™.
- Capital Cube•last month
Categories: Yahoo Finance Get free summary analysis Bioanalytical Systems, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Bioanalytical Systems, Inc. – Quintiles Transnational Holdings, Inc., Charles River Laboratories International, Inc., PAREXEL International Corporation, Harvard Bioscience, Inc., Danaher Corporation, General Electric Company, SCYNEXIS, Inc., Thermo Fisher ... Read more (Read more...)
Bioanalytical Systems Inc. (BASI)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||1.13 x 100|
|Day's Range||1.11 - 1.17|
|52wk Range||0.90 - 1.82|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-4.37|
|Avg Vol (3m)||18,682|
|Dividend & Yield||N/A (N/A)|